The 10 companies currently hosted within the Institute span a wide range of sectors and technologies. However, they are all united by one common goal: Improving patient care.

Company Technology
CyberHeart Cardiac arrhythmia affects 2.5 million Americans. Left untreated it can lead to stroke and heart failure. CyberHeart has developed the first non-invasive, automated ablation treatment for such arrhythmias.
G-Tech Medical Up to 60 million individuals in the U.S. suffer from debilitating gastrointestinal disorders. G-Tech is developing a wearable technology aimed at improving outcomes and reducing costs by non-invasively monitoring GI tract activity.
Healyx Chronic wounds affect more than 110 million people worldwide. Delayed healing can create major hardships for patients, especially in developing countries. Healyx is developing a simple, cost-effective, negative pressure wound management system to speed wound healing.
Materna Medical More than 10 percent of women in the U.S. will undergo surgery to treat a pelvic floor disorder. Materna is developing a new device aimed at reducing the incidence of childbirth-related pelvic floor damage and also a second product to treat chronic pelvic pain.
MedicalCue Each day, more than 1,100 babies born in the U.S. require assistance breathing. MedicalCue has developed a bedside device that guides medical teams through newborn resuscitation, greatly increasing the accuracy of care delivered.
palmm Fifteen million Americans suffer from hyperhidrosis, also known as excessive sweating. This condition can dramatically affect quality of life in both social and professional settings. palmm is developing a simple, at-home treatment for hyperhidrosis, initially focusing on the hands.
Radial Medical Forty percent of adults suffer from some degree of venous insufficiency which, left untreated, can lead to severe venous ulcers. Radial is addressing this condition by developing a comfortable, easy-to-use compression therapy system designed to improve circulation in the lower limbs.
Raydiant Oximetry Nearly half of all C-sections performed in the U.S. are retrospectively deemed unnecessary. Raydiant is developing a non-invasive sensor to monitor fetal oxygenation during labor, hopefully improving the diagnosing fetal distress and reducing the rate of unwarranted C-sections.
Zebra Medical Technologies Each year, patients endure 19 million biopsies for suspected skin cancers. Nearly three-quarters of these prove negative, resulting in significant costs to the healthcare system. Zebra is creating a non-invasive, real-time cellular imaging system aimed at reducing the need for traditional biopsies.
Dr. Fogarty

"We strive to create an environment where we can cost effectively develop technology that directly benefits patients."

– Thomas J. Fogarty, MD, Founder, FII